Monday - April 13, 2026

ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology

As the global race to treat metabolic dysfunction–associated steatotic liver disease (MASLD) and expand GLP-1 therapies accelerates, a critical challenge is emerging across the pharmaceutical industry: clinical trial infrastructure is struggling to scale—especially liver imaging. With trial sizes increasing, durations … Continue reading

AICC Spotlights Risks of AI Vendor Lock-In as Enterprises Embrace Unified Multi-Model APIs in 2026

Global AI infrastructure leaders warn that single-supplier dependency is costing businesses flexibility, resilience, and up to 80% in unnecessary expenses Singapore – April 13, 2026 – As the generative AI market accelerates into full-scale enterprise deployment, a growing number of organizations … Continue reading